CannaPharmaRX, Inc.
CPMD
$0.0044
-$0.0001-2.22%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 820.10K | 338.00K | 25.80K | 25.80K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 820.10K | 338.00K | 25.80K | 25.80K | -- |
| Cost of Revenue | 3.61M | 1.48M | 807.90K | 807.90K | 65.60K |
| Gross Profit | -2.79M | -1.14M | -782.10K | -782.10K | -65.60K |
| SG&A Expenses | 597.50K | -21.30K | 427.80K | 964.50K | 1.28M |
| Depreciation & Amortization | -100.00 | -8.90K | 67.70K | 77.50K | 127.90K |
| Other Operating Expenses | 51.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| Total Operating Expenses | 4.25M | 1.55M | 1.40M | 1.95M | 1.58M |
| Operating Income | -3.43M | -1.21M | -1.38M | -1.92M | -1.58M |
| Income Before Tax | -9.91M | 1.38M | 627.30K | -6.61M | 3.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.91 | 1.38 | 0.63 | -6.61 | 3.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.91M | 1.38M | 627.30K | -6.61M | 3.69M |
| EBIT | -3.43M | -1.21M | -1.38M | -1.92M | -1.58M |
| EBITDA | -3.25M | -912.30K | -934.10K | -1.54M | -1.21M |
| EPS Basic | -0.03 | 0.00 | -0.01 | -0.02 | 0.01 |
| Normalized Basic EPS | -0.02 | -0.01 | -0.02 | -0.03 | -0.01 |
| EPS Diluted | -0.03 | 0.00 | -0.01 | -0.02 | 0.01 |
| Normalized Diluted EPS | -0.02 | -0.01 | -0.02 | -0.03 | -0.01 |
| Average Basic Shares Outstanding | 2.33B | 2.03B | 1.66B | 1.30B | 1.25B |
| Average Diluted Shares Outstanding | 2.33B | 2.03B | 1.66B | 1.30B | 1.25B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |